Compare JRS & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | JRS | HURA |
|---|---|---|
| Founded | 2001 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.6M | 123.0M |
| IPO Year | N/A | 2010 |
| Metric | JRS | HURA |
|---|---|---|
| Price | $7.44 | $1.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.04 |
| AVG Volume (30 Days) | 60.2K | ★ 545.3K |
| Earning Date | 01-01-0001 | 11-13-2026 |
| Dividend Yield | ★ 8.87% | N/A |
| EPS Growth | N/A | ★ 47.93 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.12 | $0.41 |
| 52 Week High | $8.90 | $3.43 |
| Indicator | JRS | HURA |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 33.39 |
| Support Level | $7.12 | $1.27 |
| Resistance Level | $8.32 | $2.22 |
| Average True Range (ATR) | 0.15 | 0.16 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 22.81 | 13.38 |
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund s investment objective is to provide total return through high current income and capital appreciation.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.